Rockwell Medical (STU:RWMA) ROE % Adjusted to Book Value : 5.76% (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Rockwell Medical ROE % Adjusted to Book Value?

Rockwell Medical's ROE % for the quarter that ended in Sep. 2024 was 24.94%. Rockwell Medical's PB Ratio for the quarter that ended in Sep. 2024 was 4.33. Rockwell Medical's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 5.76%.

Rockwell Medical ROE % Adjusted to Book Value Historical Data

The historical data trend for Rockwell Medical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rockwell Medical ROE % Adjusted to Book Value Chart

Rockwell Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-19.54

-44.33

-14.30

-260.53

-18.20

Rockwell Medical Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-18.36	-10.80	-14.26	2.72	5.76

Competitive Comparison of Rockwell Medical's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rockwell Medical's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Rockwell Medical's ROE % Adjusted to Book Value falls into.

Rockwell Medical ROE % Adjusted to Book Value Calculation

Rockwell Medical's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-47.13%	/	2.59
	=	-18.20%

Rockwell Medical's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	24.94%	/	4.33
	=	5.76%

Rockwell Medical ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Rockwell Medical's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Rockwell Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rockwell Medical Inc (STU:RWMA) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

RMTI:USA RWMA:Germany

Address

30142 S. Wixom Road, Wixom, MI, USA, 48393

Website

https://www.rockwellmed.com

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.

Rockwell Medical Headlines

No Headlines